Literature DB >> 16177239

Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury.

Lauren M Aleksunes1, George L Scheffer, Amy B Jakowski, Ingrid M Pruimboom-Brees, José E Manautou.   

Abstract

Following acute chemical injury, hepatocytes are generally more resistant to toxicant re-exposure. Alterations in expression of hepatobiliary transport systems may contribute to this resistance by preventing accumulation of potentially toxic chemicals. Previous data demonstrate the concomitant reduction of uptake transporter and induction of efflux transporter mRNA during chemical liver injury. The present study further characterizes the expression of multidrug resistance-associated proteins 1-4 (Mrp1-4), breast cancer resistance protein (Bcrp) and sodium-taurocholate co-transporting polypeptide (Ntcp) in mouse liver following administration of the hepatotoxicants acetaminophen (APAP) and carbon tetrachloride (CCl4). Mice received hepatotoxic doses of APAP (400 mg/kg), CCl4 (10 or 25 microl/kg), or vehicle, ip. Livers were collected at 6, 24, and 48 h for Western blot quantification and immunofluorescence analysis. Protein expression of Bcrp was unchanged with treatment. Ntcp levels were preserved in APAP-exposed livers and reduced to 30-50% of control after CCl4. Conversely, Mrp1-4 expression was differentially up-regulated. CCl4 increased Mrp1 (3.5-fold), Mrp2 (1.4-fold), and Mrp4 (26-fold) while reducing Mrp3 levels to 20% of control. Administration of APAP enhanced expression of Mrp2 (1.6-fold), Mrp3 (3.5-fold), and Mrp4 (16-fold). Immunostaining of liver sections obtained 48 h after hepatotoxicant treatment confirmed expression patterns of a subset of transporters (Bcrp, Ntcp, Mrp3, and Mrp4). Double immunofluorescence imaging demonstrated the simultaneous down-regulation of Ntcp and up-regulation of Mrp4 in hepatocytes adjacent to the central vein after CCl4. Altered expression of transporters may reduce the overall chemical burden of an injured liver during recovery and contribute to the resistance of hepatocytes to subsequent toxicant exposure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177239     DOI: 10.1093/toxsci/kfi332

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  34 in total

1.  Renal efflux transporter expression in pregnant mice with Type I diabetes.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  Toxicol Lett       Date:  2012-04-17       Impact factor: 4.372

2.  Analysis of changes in hepatic gene expression in a murine model of tolerance to acetaminophen hepatotoxicity (autoprotection).

Authors:  Meeghan A O'Connor; Petra Koza-Taylor; Sarah N Campion; Lauren M Aleksunes; Xinsheng Gu; Ahmed E Enayetallah; Michael P Lawton; José E Manautou
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-11       Impact factor: 4.219

3.  Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization.

Authors:  Woo-Jae Park; Joo-Won Park; Racheli Erez-Roman; Aviram Kogot-Levin; Jessica R Bame; Boaz Tirosh; Ann Saada; Alfred H Merrill; Yael Pewzner-Jung; Anthony H Futerman
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

4.  Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity.

Authors:  Shiyun Pu; Lin Ren; Qinhui Liu; Jiangying Kuang; Jing Shen; Shihai Cheng; Yuwei Zhang; Wei Jiang; Zhiyong Zhang; Changtao Jiang; Jinhan He
Journal:  Br J Pharmacol       Date:  2015-11-16       Impact factor: 8.739

5.  Is nuclear factor erythroid 2-related factor 2 responsible for sex differences in susceptibility to acetaminophen-induced hepatotoxicity in mice?

Authors:  Philip R Rohrer; Swetha Rudraiah; Michael J Goedken; José E Manautou
Journal:  Drug Metab Dispos       Date:  2014-08-04       Impact factor: 3.922

Review 6.  Multidrug resistance-associated proteins 3, 4, and 5.

Authors:  Piet Borst; Cornelia de Wolf; Koen van de Wetering
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

7.  Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta.

Authors:  Lauren M Aleksunes; Yue Cui; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2008-06-19       Impact factor: 3.922

8.  Reduced exposure of imatinib after coadministration with acetaminophen in mice.

Authors:  Inthisham Nassar; Thanikachalam Pasupati; John Paul Judson; Ignacio Segarra
Journal:  Indian J Pharmacol       Date:  2009-08       Impact factor: 1.200

9.  Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice.

Authors:  Iván L Csanaky; Lauren M Aleksunes; Yuji Tanaka; Curtis D Klaassen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-04       Impact factor: 4.052

10.  Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.

Authors:  Craig D Fisher; Andrew J Lickteig; Lisa M Augustine; Ronald P J Oude Elferink; David G Besselsen; Robert P Erickson; Nathan J Cherrington
Journal:  Eur J Pharmacol       Date:  2009-04-07       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.